EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that Ron Najafi, Ph.D., Chairman and CEO, will present a company update at the Rodman & Renshaw Healthcare Conference, held September 8-10, 2014 in New York City. Dr. Najafi along with Tom Paulson, Chief Financial Officer will be available to respond to questions and to participate in one-on-one meetings with investors attending the conference.
Help employers find you! Check out all the jobs and post your resume.
